查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
獸用抗生素和抗菌劑市場規模、佔有率和成長分析（按類型、劑型、動物和地區分類）—產業預測（2026-2033 年）
市場調查報告書
商品編碼
1896082

獸用抗生素和抗菌劑市場規模、佔有率和成長分析（按類型、劑型、動物和地區分類）—產業預測（2026-2033 年）

Animal Antibiotics and Antimicrobials Market Size, Share, and Growth Analysis, By Type (Tetracyclines, Penicillins), By Delivery (Premixes, Oral Powder), By Animal, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球獸用抗生素和抗菌藥物市場預計到 2024 年將達到 47.8 億美元，到 2025 年將達到 49.5 億美元，到 2033 年將達到 65.2 億美元，預測期（2026-2033 年）的複合年成長率為 3.5%。

全球獸用抗生素和抗菌藥物市場在動物醫藥領域發揮著至關重要的作用，其主要驅動力是肉類、牛奶和雞蛋消費量成長帶來的動物性蛋白質需求快速成長。而全球人口成長和可支配收入增加又推動了畜牧業的擴張，進而刺激了這項需求的激增。同時，動物感染疾病（例如感染疾病和胃腸道感染疾病）的傳播對動物健康構成重大威脅，增加了對用於疾病預防和治療的抗生素和抗菌藥物的需求。此外，人們對動物福利的日益關注以及限制通用感染疾病傳播的必要性，凸顯了這些產品在維持動物健康、生長和生產力方面的重要性，進一步鞏固了它們在市場中的關鍵地位。

獸用抗生素和抗菌藥物市場促進因素

動物感染疾病（例如禽流感、口蹄疫和豬霍亂）的日益流行凸顯了使用抗生素和抗菌藥物預防和控制疫情的必要性。疾病造成的經濟損失推動了對這些產品的需求，尤其是在這些疾病高發生率地區。這種不斷成長的需求主要源於保護動物健康和確保畜牧業生產力的需要。因此，隨著動物健康日益受到重視，為應對這些緊迫的挑戰，抗生素和抗菌藥物市場也持續擴張。

動物用抗生素和抗菌劑市場的限制

隨著消費者對食品安全和永續性的偏好不斷提高，對無抗生素畜產品的需求日益成長。消費者對抗生素在畜牧生產的影響認知不斷加深，生產者面臨越來越大的壓力，不得不採用無抗生素的生產方式。這種轉變對獸用抗生素和抗菌藥物的需求產生了負面影響，因為生產者需要調整其生產方式以適應市場趨勢和消費者期望。因此，畜牧業內部出現了一股明顯的趨勢，即探索強調永續性和減少抗生素使用的替代疾病預防和生長促進策略，這進一步抑制了傳統抗生素的市場需求。

動物抗生素和抗菌劑市場趨勢

獸用抗生素和抗菌藥物市場正經歷顯著的變革，其驅動力在於人們對合理用藥的日益關注以及對抗生素替代品的探索。消費者對抗菌素抗藥性（AMR）的認知不斷提高，以及監管壓力，迫使相關人員實施創新策略，在保障動物健康的同時降低AMR風險。因此，益生菌、益生元、植物性抗菌劑和疫苗等替代品越來越受到關注，它們正逐漸成為提高牲畜生產力和福祉的有效解決方案。這一趨勢反映了人們正朝著永續畜牧業實踐邁進，力求在確保食品安全和公眾健康的同時，滿足消費者和監管機構日益成長的期望。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球動物抗生素和抗菌劑市場按類型分類，複合年成長率（2026-2033 年）

  • 四環黴素
  • 青黴素
  • 磺胺類藥物
  • 大環內酯類
  • Aminoglycosides
  • 林可醯胺類
  • Fluoroquinolones
  • 頭孢菌素
  • 其他抗生素和抗菌劑

全球動物抗生素和抗菌劑市場按劑型分類，複合年成長率（2026-2033 年）

  • 預混合料
  • 口服粉劑
  • 口服液
  • 注射
  • 其他

全球動物抗生素和抗菌劑市場（按物種分類），複合年成長率（2026-2033 年）

  • 食用動物
    • 牛
    • 豬
    • 家禽
    • 綿羊/山羊
    • 其他食用動物
  • 寵物
    • 狗
    • 貓
    • 馬
    • 其他寵物

全球動物抗生素和抗菌劑市場規模、複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

  • Zoetis Inc.（USA）
  • Merck & Co., Inc.（USA）
  • Elanco Animal Health Incorporated（USA）
  • Boehringer Ingelheim International GmbH（Germany）
  • Ceva Sante Animale（France）
  • Virbac（France）
  • Vetoquinol（France）
  • Bayer AG（Germany）
  • Novartis AG（Switzerland）
  • Eli Lilly and Company（USA）
  • Sanofi（France）
  • Intervet Inc.（Netherlands）
  • Alltech（Ireland）
  • Huvepharma（Bulgaria）
  • Kemin Industries（USA）
  • Novus International（USA）
  • Biomin Holding GmbH（Austria）
  • ADM Animal Nutrition（USA）
  • Adisseo（France）
  • DSM（Netherlands）

結論與建議

簡介目錄
Product Code: SQMIG35A2329

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.78 Billion in 2024 and is poised to grow from USD 4.95 Billion in 2025 to USD 6.52 Billion by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

The global market for animal antibiotics and antimicrobials plays a crucial role in veterinary pharmaceuticals, primarily driven by the surging demand for animal protein as meat, milk, and eggs consumption escalates. This spike is influenced by a growing global population and increased disposable incomes, prompting a rise in livestock production. Simultaneously, the prevalence of infectious diseases in animals, such as respiratory and gastrointestinal infections, poses significant risks to animal health, thereby elevating the demand for antibiotics and antimicrobials for disease prevention and treatment. Furthermore, heightened awareness regarding animal welfare and the need to limit zoonotic disease transmission underscores the importance of these products in ensuring optimal animal health, growth, and productivity, reinforcing their indispensable role in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Antibiotics and Antimicrobials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Antibiotics and Antimicrobials Market Segments Analysis

Global Animal Antibiotics And Antimicrobials Market is segmented by type, delivery, animal and region. Based on type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins and other antimicrobials and antibiotics. Based on delivery, the market is segmented into premixes, oral powder, oral solution, injection and others. Based on animal, the market is segmented into food-producing animals and companion animals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Animal Antibiotics and Antimicrobials Market

The rising prevalence of infectious diseases in animals, including avian influenza, foot-and-mouth disease, and swine fever, highlights the critical need for antibiotics and antimicrobials to prevent and manage these outbreaks. The economic repercussions tied to disease-related losses propel the demand for these products, especially in areas where such illnesses are more common. This heightened demand is primarily driven by the imperative to safeguard animal health and ensure productivity levels within the livestock sector. Consequently, as animal health becomes increasingly prioritized, the market for antibiotics and antimicrobials continues to expand in response to these pressing challenges.

Restraints in the Animal Antibiotics and Antimicrobials Market

Shifting consumer preferences towards food safety and sustainability have led to a growing demand for antibiotic-free animal products. As consumers become more aware of the implications of antibiotic use in livestock, producers increasingly feel compelled to adopt antibiotic-free production practices. This transition adversely affects the demand for animal antibiotics and antimicrobials, as producers seek to align their operations with market trends and consumer expectations. Consequently, there is a notable movement towards exploring alternative disease prevention and growth promotion strategies in animal husbandry, emphasizing sustainability and the reduction of antibiotic usage, which further constrains the conventional antibiotics market.

Market Trends of the Animal Antibiotics and Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is witnessing a significant transformation fueled by a heightened focus on responsible use and the search for antibiotic alternatives. Increasing awareness of antimicrobial resistance (AMR) among consumers, alongside regulatory pressures, is prompting stakeholders to adopt innovative strategies that prioritize animal health while mitigating AMR risks. Consequently, there's a growing interest in alternatives such as probiotics, prebiotics, phytogenics, and vaccines, which are emerging as effective solutions to enhance livestock performance and welfare. This trend reflects a collective movement towards sustainable animal farming practices, ensuring food safety and public health while meeting the evolving expectations of consumers and regulators alike.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Animal Antibiotics And Antimicrobials Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Lincosamides
  • Fluoroquinolones
  • Cephalosporins
  • Other Antimicrobials And Antibiotics

Global Animal Antibiotics And Antimicrobials Market Size by Delivery & CAGR (2026-2033)

  • Market Overview
  • Premixes
  • Oral Powder
  • Oral Solution
  • Injection
  • Others

Global Animal Antibiotics And Antimicrobials Market Size by Animal & CAGR (2026-2033)

  • Market Overview
  • Food-Producing Animals
    • Cattle
    • Pigs
    • Poultry
    • Sheep And Goats
    • Other Food-Producing Animals
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals

Global Animal Antibiotics And Antimicrobials Market Size & CAGR (2026-2033)

  • North America (Type, Delivery, Animal)
    • US
    • Canada
  • Europe (Type, Delivery, Animal)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Delivery, Animal)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Delivery, Animal)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Delivery, Animal)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Zoetis Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco Animal Health Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Sante Animale (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetoquinol (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intervet Inc. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alltech (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Huvepharma (Bulgaria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kemin Industries (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novus International (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomin Holding GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ADM Animal Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Adisseo (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations